Related Experiment Video

Updated: May 19, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

[Metastatic infections in children with Staphylococcus aureus bacteremia]

María L Praino1, Silvina E Neyro, Adriana Procopio

  • 1Hospital de Niños Dr. Ricardo Gutiérrez, Ciudad de Buenos Aires. mlpraino@hotmail.com

Archivos Argentinos De Pediatria
|August 4, 2012
PubMed

Insights

Staphylococcus aureus bacteremia (SAB) in children can lead to metastatic infections, occurring in 15.8% of cases. Persistent positive blood cultures over 48 hours were identified as a key risk factor.

Area of Science:

  • Pediatric Infectious Diseases
  • Bacteremia and Sepsis Research
  • Clinical Microbiology

Context:

  • Staphylococcus aureus is a frequent pediatric pathogen causing diverse infections.
  • Staphylococcus aureus bacteremia (SAB) complications are well-documented in adults but less understood in children.
  • Clinical guidelines lack consensus on investigating metastatic infections in pediatric SAB.

Purpose:

  • To determine the frequency and characteristics of secondary impacts of SAB in pediatric patients.
  • To identify potential risk factors associated with the development of metastatic infections in pediatric SAB.
  • To inform diagnostic strategies for complications in pediatric Staphylococcus aureus bacteremia.

Summary:

  • This study analyzed pediatric patients with Staphylococcus aureus bacteremia (SAB) over two years at "Hospital Gutierrez".
  • A metastatic infection rate of 15.8% was observed.
  • Persistence of positive blood cultures for more than 48 hours emerged as the primary risk factor for secondary complications.

Impact:

  • Findings highlight the significant risk of metastatic infections in pediatric SAB.
  • Identifies prolonged positive blood cultures as a critical indicator for further investigation.
  • Contributes to a better understanding of SAB complications in children, aiding clinical decision-making.

More Related Videos

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus08:32

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus

Published on: January 17, 2025

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...